
The clearest direction yet that Medication Adherence Solutions should be implemented to ensure optimised clinical trial outcomes.
This guidance responds to requests by the World Health
Assembly to the Director-General in resolution WHA75.8
(2022) on strengthening clinical trials. It aims to provide
the following…
- High-quality evidence on health interventions to improve research quality and coordination
- Identify and propose best practices and other measures to strengthen the global clinical trial ecosystem
- Review existing guidance and develop new guidance as needed on best practices for clinical trials
- Enhance clinical research efficiency and minimize research waste
- Provide guidance on sustained clinical trials that are always functional and active for endemic conditions and can pivot in time of emergency or pandemics.